Another key anti-apoptotic protein, Mcl-1, plays a particularly important role in BRAF-mutant melanomas; in these tumors, MAPK pathway hyperactivation drives both increased MCL1 transcription and stabilization of Mcl-1 protein through phosphorylation at threonine 163, preventing its degradation [104–108]. Here, MCL1 is linked to melanoma.